Evidence map›Paper›PMID 39201957›Full record

ArticleChildren (Basel, Switzerland)2024

Long-Term Socioeconomic and Neurologic Outcome for Individuals with Childhood-Onset Multiple Sclerosis.

Moritz Tacke, Iris Hannibal, Katharina Vill, Michaela V Bonfert, Wolfgang Müller-Felber, Astrid Blaschek

Abstract read
In one paragraph

Article in Children (Basel, Switzerland), 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Moritz TackeDepartment of Pediatrics, Division of Pediatric Neurology, MUC iSPZ Hauner-Munich University Center for Children with Medical and Developmental Complexity, Dr. von Hauner Children's Hospital, LMU University Hospital, 80337 Munich, Germany.ORCID 0000-0002-7192-5671
Iris HannibalDepartment of Pediatrics, Division of Pediatric Neurology, MUC iSPZ Hauner-Munich University Center for Children with Medical and Developmental Complexity, Dr. von Hauner Children's Hospital, LMU University Hospital, 80337 Munich, Germany.
Katharina VillDepartment of Pediatrics, Division of Pediatric Neurology, MUC iSPZ Hauner-Munich University Center for Children with Medical and Developmental Complexity, Dr. von Hauner Children's Hospital, LMU University Hospital, 80337 Munich, Germany.
Michaela V BonfertDepartment of Pediatrics, Division of Pediatric Neurology, MUC iSPZ Hauner-Munich University Center for Children with Medical and Developmental Complexity, Dr. von Hauner Children's Hospital, LMU University Hospital, 80337 Munich, Germany.ORCID 0000-0003-0995-9050
Wolfgang Müller-FelberDepartment of Pediatrics, Division of Pediatric Neurology, MUC iSPZ Hauner-Munich University Center for Children with Medical and Developmental Complexity, Dr. von Hauner Children's Hospital, LMU University Hospital, 80337 Munich, Germany.
Astrid BlaschekDepartment of Pediatrics, Division of Pediatric Neurology, MUC iSPZ Hauner-Munich University Center for Children with Medical and Developmental Complexity, Dr. von Hauner Children's Hospital, LMU University Hospital, 80337 Munich, Germany.ORCID 0000-0003-2918-0159

Funding

Merck (Germany) 2022-1
6 · The paper itself

Abstract

intorductionMost studies on the progression of childhood-onset multiple sclerosis (MS) involve relatively short follow-up periods, focusing primarily on neurological outcomes and disability progression. The influence of these and other factors on the health-related quality of life is not known. To gain a comprehensive understanding of early-onset MS, it is crucial to evaluate the effects of treatment and the disease on quality of life.

methodThis pilot project aimed to evaluate the feasibility of using an online survey tool for long-term follow-up data collection from patients with childhood-onset MS. An anonymized, monocentric, prospective survey was conducted on a convenience cohort of patients treated at a certified centre for neuromuscular diseases in childhood between 2007 and 2019.

resultsA total of 27 patients completed the survey. There were no mandatory items, therefore some patients chose not to answer all the questions in the questionnaire. Patients exhibited promising educational achievements, low neurological disease burden, and high resilience. However, anxiety, depression, and pain significantly impacted their perceived health status.

conclusionThis single-centre study has yielded new insights into childhood-onset MS. To enable more accurate comparisons across different centres and countries, it is essential to establish a minimum data set and questionnaire subset for patients with paediatric-onset MS transitioning into adulthood.

Indexed as

adolescent medicineearly onsetEQ-5D 5LMSIS29multiple sclerosisnatural historypaediatric onsetquality of lifesocioeconomic

Identifiers

PMID39201957
PMCPMC11352636

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.